Cargando…
Atherosclerosis in HIV Patients: What Do We Know so Far?
For the past several decades, humanity has been dealing with HIV. This disease is one of the biggest global health problems. Fortunately, modern antiretroviral therapy allows patients to manage the disease, improving their quality of life and their life expectancy. In addition, the use of these drug...
Autores principales: | Poznyak, Anastasia V., Bezsonov, Evgeny E., Borisov, Evgeny E., Grechko, Andrey V., Kartuesov, Andrey G., Orekhov, Alexander N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910073/ https://www.ncbi.nlm.nih.gov/pubmed/35269645 http://dx.doi.org/10.3390/ijms23052504 |
Ejemplares similares
-
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
por: Poznyak, Anastasia V., et al.
Publicado: (2022) -
Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
por: Poznyak, Anastasia V., et al.
Publicado: (2022) -
Vaccination against Atherosclerosis: Is It Real?
por: Poznyak, Anastasia V., et al.
Publicado: (2022) -
Immunity in Atherosclerosis: Focusing on T and B Cells
por: Poznyak, Anastasia V., et al.
Publicado: (2021) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022)